Found: 40
Select item for more details and to access through your institution.
Water content and myelin water fraction in multiple sclerosis: A T<sub>2</sub> relaxation study.
- Published in:
- Journal of Neurology, 2004, v. 251, n. 3, p. 284, doi. 10.1007/s00415-004-0306-6
- By:
- Publication type:
- Article
Rapsyn Antibodies in Myasthenia Gravis<sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 1998, v. 841, n. 1, p. 516, doi. 10.1111/j.1749-6632.1998.tb10972.x
- By:
- Publication type:
- Article
Thymus Histology and Acetylcholine Receptor Antibodies in Generalized Myasthenia Gravis.
- Published in:
- Annals of the New York Academy of Sciences, 1993, v. 681, n. 1, p. 110, doi. 10.1111/j.1749-6632.1993.tb22877.x
- By:
- Publication type:
- Article
Glinical evaluation of a staphylococcal protein A immunoadsorption system in the treatment of myasthenia gravis patients
- Published in:
- Transfusion, 1999, v. 39, n. 7, p. 682
- By:
- Publication type:
- Article
Clinical evaluation of a staphylococcal protein A immunoadsorption system in the treatment of myasthenia gravis patients.
- Published in:
- 1999
- By:
- Publication type:
- journal article
False-positive amniotic fluid acetylcholinesterase PAGE due to contamination by the AFP diluent of an automated instrument.
- Published in:
- Prenatal Diagnosis, 2004, v. 24, n. 6, p. 478, doi. 10.1002/pd.699
- By:
- Publication type:
- Article
Reduction of immunoglobulin G secretion in vitro following long term lymphoblastoid interferon (Wellferon) treatment in multiple sclerosis patients.
- Published in:
- Clinical & Experimental Immunology, 1987, v. 67, n. 1, p. 66
- By:
- Publication type:
- Article
Kinetics of interaction of immune complexes with complement receptors on human blood cells: modification of complexes during interaction with red cells.
- Published in:
- Clinical & Experimental Immunology, 1982, v. 48, n. 3, p. 715
- By:
- Publication type:
- Article
Differences in interaction between immune complexes and complement receptors in serum and cerebrospinal fluid.
- Published in:
- Clinical & Experimental Immunology, 1982, v. 48, n. 1, p. 25
- By:
- Publication type:
- Article
Generation of suppressor cells by aggregated human globulin.
- Published in:
- Clinical & Experimental Immunology, 1981, v. 43, n. 2, p. 351
- By:
- Publication type:
- Article
Changes in Immune Function in Relapsing Multiple Sclerosis Correlate with Disease Activity As Assessed by Magnetic Resonance Imaging.
- Published in:
- Annals of the New York Academy of Sciences, 1988, v. 540, n. 1, p. 597, doi. 10.1111/j.1749-6632.1988.tb27185.x
- By:
- Publication type:
- Article
Reduced OKT8<sup>+</sup> and OKT3<sup>+</sup> Cells in Blood of Progressive MS Patients.
- Published in:
- Annals of the New York Academy of Sciences, 1984, v. 436, n. 1, p. 506, doi. 10.1111/j.1749-6632.1984.tb14832.x
- By:
- Publication type:
- Article
Beta-interferon exposure and onset of secondary progressive multiple sclerosis.
- Published in:
- European Journal of Neurology, 2015, v. 22, n. 6, p. 990, doi. 10.1111/ene.12698
- By:
- Publication type:
- Article
Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study.
- Published in:
- European Journal of Neurology, 2014, v. 21, n. 6, p. 835, doi. 10.1111/ene.12324
- By:
- Publication type:
- Article
Potassium channel antibodies in two patients with reversible limbic encephalitis.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis.
- Published in:
- Annals of Neurology, 1994, v. 36, n. S1, p. S95, doi. 10.1002/ana.410360721
- By:
- Publication type:
- Article
Chronic progressive multiple sclerosis: Serial magnetic resonance brain imaging over six months.
- Published in:
- Annals of Neurology, 1989, v. 26, n. 2, p. 248, doi. 10.1002/ana.410260211
- By:
- Publication type:
- Article
Serial magnetic resonance scanning in multiple sclerosis: A second prospective study in relapsing patients.
- Published in:
- Annals of Neurology, 1989, v. 25, n. 1, p. 43, doi. 10.1002/ana.410250107
- By:
- Publication type:
- Article
Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 1, p. 112, doi. 10.1177/1352458515586086
- By:
- Publication type:
- Article
‘Clinically definite benign multiple sclerosis’, an unwarranted conceptual hodgepodge: evidence from a 30-year observational study.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 4, p. 458, doi. 10.1177/1352458512456613
- By:
- Publication type:
- Article
High-dose frequency beta-interferons increase the risk of liver test abnormalities in multiple sclerosis: a longitudinal study.
- Published in:
- Multiple Sclerosis Journal, 2011, v. 17, n. 3, p. 361, doi. 10.1177/1352458510388823
- By:
- Publication type:
- Article
Neutralising Antibodies to Interferon-β in the Treatment of Multiple Sclerosis: Cause for Concern?
- Published in:
- CNS Drugs, 1999, v. 11, n. 3, p. 225, doi. 10.2165/00023210-199911030-00006
- By:
- Publication type:
- Article
P.042 Could Live Cell-Based Assay increase the acetylcholine receptor autoantibodies seropositivity in patients with clinical suspicion of myasthenia gravis?
- Published in:
- 2023
- By:
- Publication type:
- Abstract
P.033 Detection of Myelin Oligodendrocyte Glycoprotein Immunoglobulin G (MOG-IgG) by live and fixed cell-based assays.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Two-year study of cervical cord volume and myelin water in primary progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis (13524585), 2010, v. 16, n. 6, p. 670, doi. 10.1177/1352458510365586
- By:
- Publication type:
- Article
Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?
- Published in:
- Multiple Sclerosis (13524585), 2009, v. 15, n. 8, p. 959, doi. 10.1177/1352458509106230
- By:
- Publication type:
- Article
Ten years of adverse drug reaction reports for the multiple sclerosis immunomodulatory therapies: a Canadian perspective.
- Published in:
- Multiple Sclerosis (13524585), 2008, v. 14, n. 1, p. 94, doi. 10.1177/1352458507079658
- By:
- Publication type:
- Article
Reduced effectiveness of long-term interferon-β treatment on relapses in neutralizing antibody-positive multiple sclerosis patients: a Canadian multiple sclerosis clinic-based study.
- Published in:
- Multiple Sclerosis (13524585), 2007, v. 13, n. 9, p. 1127
- By:
- Publication type:
- Article
Binding antibodies: Vancouver's perspective.
- Published in:
- Multiple Sclerosis (13524585), 2007, v. 13, p. S36, doi. 10.1177/1352458507076989
- By:
- Publication type:
- Article
Neutralizing antibodies and interferon treatment of multiple sclerosis: addressing the open questions.
- Published in:
- Multiple Sclerosis (13524585), 2007, v. 13, p. S5, doi. 10.1177/1352458507076988
- By:
- Publication type:
- Article
Binding antibodies: Vancouver's perspective.
- Published in:
- Multiple Sclerosis (13524585), 2007, v. 13, n. 3, p. S36, doi. 10.1177/1352458507076989
- By:
- Publication type:
- Article
Neutralizing antibodies and interferon treatment of multiple sclerosis: addressing the open questions.
- Published in:
- Multiple Sclerosis (13524585), 2007, v. 13, n. 3, p. S5, doi. 10.1177/1352458507076988
- By:
- Publication type:
- Article
Co-occurrence of multiple sclerosis and myasthenia gravis in British Columbia.
- Published in:
- Multiple Sclerosis (13524585), 2003, v. 9, n. 6, p. 550, doi. 10.1191/1352458503ms964oa
- By:
- Publication type:
- Article
Clinical presentation of primary progressive multiple sclerosis 10 years after the incidental finding of typical magnetic resonance imaging brain lesions: The subclinical stage of primary progressive multiple sclerosis may last 10 years.
- Published in:
- Multiple Sclerosis (13524585), 2003, v. 9, n. 2, p. 204, doi. 10.1191/1352458503ms890cr
- By:
- Publication type:
- Article
Informing Medication Discontinuation Decisions among Older Adults with Relapsing-Onset Multiple Sclerosis.
- Published in:
- Drugs & Aging, 2020, v. 37, n. 3, p. 225, doi. 10.1007/s40266-019-00741-1
- By:
- Publication type:
- Article
Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid disease.
- Published in:
- Acta Neurologica Scandinavica, 2006, v. 114, n. 2, p. 124, doi. 10.1111/j.1600-0404.2006.00649.x
- By:
- Publication type:
- Article
Analysis of effector CD4 (OX‐40<sup>+</sup>) and CD8 (CD45RA<sup>+</sup>CD27<sup>-</sup>) T lymphocytesin active multiple sclerosis.
- Published in:
- Acta Neurologica Scandinavica, 2000, v. 101, n. 1, p. 57, doi. 10.1034/j.1600-0404.2000.00007.x
- By:
- Publication type:
- Article
Low T8 antigen density on lymphocytes in active multiple sclerosis.
- Published in:
- Annals of Neurology, 1984, v. 16, n. 2, p. 242, doi. 10.1002/ana.410160214
- By:
- Publication type:
- Article
Influence of azathioprine (Imuran) on in vitro immune function in multiple sclerosis.
- Published in:
- Annals of Neurology, 1982, v. 11, n. 2, p. 177, doi. 10.1002/ana.410110211
- By:
- Publication type:
- Article
Cell-mediated immunity in idiopathic polyneuritis.
- Published in:
- Annals of Neurology, 1981, v. 9, n. S1, p. 65, doi. 10.1002/ana.410090711
- By:
- Publication type:
- Article